Atossa Therapeutics
ATOS
#10043
Rank
A$58.48 M
Marketcap
A$6.79
Share price
2.00%
Change (1 day)
364.79%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: A$58.48 Million

As of May 2026 Atossa Therapeutics has a market cap of A$58.48 Million. This makes Atossa Therapeutics the world's 10043th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026A$58.48 M-53.97%
2025A$0.12 B-35.96%
2024A$0.19 B22.6%
2023A$0.16 B64.58%
2022A$98.34 M-64.81%
2021A$0.27 B375.7%
2020A$58.74 M186.91%
2019A$20.47 M141.88%
2018A$8.46 M-21.04%
2017A$10.72 M44.68%
2016A$7.4 M-48.35%
2015A$14.34 M-66.58%
2014A$42.92 M-11.16%
2013A$48.31 M-0.36%
2012A$48.48 M

End of Day market cap according to different sources

On May 20th, 2026 the market cap of Atossa Therapeutics was reported to be:

A$58.48 Million
by Nasdaq info icon info icon
A$58.48 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$774.59 B 1,324,353.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$30.09 B 51,358.22%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$29.61 B 50,544.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$3.96 B 6,675.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
A$1.62 B 2,680.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A$51.34 M-12.22%๐Ÿ‡บ๐Ÿ‡ธ USA